BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32805070)

  • 1. Effect of immunoadsorption alone or combined with membrane filtration on hemostasis parameters.
    Marlu R; Bennani HN; Seyve L; Malvezzi P; Janbon B; Noble J; Christophe M; Motte L; Imerzoukene F; Chevallier E; Rostaing L; Jouve T
    J Clin Apher; 2020 Sep; 35(5):444-452. PubMed ID: 32805070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined treatment with immunoadsorption and membrane filtration on plasma coagulation--Results of a randomized controlled crossover study.
    Biesenbach P; Eskandary F; Ay C; Wiegele M; Derfler K; Schaden E; Haslacher H; Oberbauer R; Böhmig GA
    J Clin Apher; 2016 Feb; 31(1):29-37. PubMed ID: 25919120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis.
    Marlu R; Naciri Bennani H; Seyve L; Noble J; Chevallier E; Motte L; Imerzoukene F; Bugnazet M; Christophe M; Malvezzi P; Jouve T; Rostaing L
    J Clin Apher; 2021 Jun; 36(3):408-419. PubMed ID: 33506958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.
    Marlu R; Malvezzi P; Seyve L; Jouve T; Maurizi J; Defendi F; Carron PL; Christophe M; Le Gouellec A; Polack B; Rostaing L
    Thromb Res; 2018 Jun; 166():113-121. PubMed ID: 29747114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunoadsorption combined with membrane filtration on complement markers - results of a randomized, controlled, crossover study.
    Defendi F; Malvezzi P; Eskandary F; Cesbron JY; Rostaing L; Böhmig GA; Dumestre-Pérard C
    Transpl Int; 2019 Aug; 32(8):876-883. PubMed ID: 30901502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trial.
    Eskandary F; Wahrmann M; Biesenbach P; Sandurkov C; König F; Schwaiger E; Perkmann T; Künig S; Derfler K; Zlabinger GJ; Böhmig GA
    Nephrol Dial Transplant; 2014 Mar; 29(3):706-14. PubMed ID: 24378525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
    Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
    Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
    Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
    J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Centrifugation in the Routine Hemostasis Laboratory.
    Wolfensberger N; Georgiou G; Giabbani E; Reusser M; Njue LM; Fiedler M; Leichtle AB; Nagler M
    Thromb Haemost; 2019 Dec; 119(12):2025-2033. PubMed ID: 31600807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and cord blood hemostasis at delivery.
    Schneider DM; von Tempelhoff GF; Herrle B; Heilmann L
    J Perinat Med; 1997; 25(1):55-61. PubMed ID: 9085204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the efficacy of three techniques to reduce isoagglutinin titers in AB0 incompatible kidney transplant recipients.
    Parmentier SP; Rosenkranz E; Schirutschke H; Opgenoorth M; Quick C; Hoelig K; Rosner A; Hohenstein B; Hugo C; Passauer J
    Atheroscler Suppl; 2017 Nov; 30():253-256. PubMed ID: 29096846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis.
    Lin SM; Yeh JH; Lee CC; Chiu HC
    J Clin Apher; 2003; 18(2):67-70. PubMed ID: 12874818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro.
    Thomas KA; Shea SM; Spinella PC
    Transfusion; 2021 Jun; 61(6):1943-1954. PubMed ID: 33755208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.
    Aznar JA; Bonanad S; Montoro JM; Hurtado C; Cid AR; Soler MA; De Miguel A
    Vox Sang; 2000; 79(3):156-60. PubMed ID: 11111234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption.
    Morath C; Becker LE; Leo A; Beimler J; Klein K; Seckinger J; Kihm LP; Schemmer P; Macher-Goeppinger S; Wahrmann M; Böhmig GA; Opelz G; Süsal C; Zeier M; Schwenger V
    Transplantation; 2012 Apr; 93(8):827-34. PubMed ID: 22382504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive Models.
    Jouve T; Marlu R; Malvezzi P; Seyve L; Maurizi J; Carron PL; Polack B; Rostaing L
    Blood Purif; 2018; 46(3):239-245. PubMed ID: 29972828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption and hemodialysis as a tandem procedure: a single-center experience of more than 60 procedures.
    Maggioni S; Allal A; Kamar N; Hermelin M; Faubel E; Rostaing L
    Int J Artif Organs; 2015 Jun; 38(6):304-10. PubMed ID: 26242846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to improve clotting factors depletion in double-filtration plasmapheresis.
    Naciri Bennani H; Marlu R; Terrec F; Motte L; Seyve L; Chevallier E; Malvezzi P; Jouve T; Rostaing L; Noble J
    J Clin Apher; 2021 Oct; 36(5):766-774. PubMed ID: 34339059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days.
    von Heymann C; Keller MK; Spies C; Schuster M; Meinck K; Sander M; Wernecke KD; Kiesewetter H; Pruss A
    Transfusion; 2009 May; 49(5):913-20. PubMed ID: 19159416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to implement immunoadsorption in a polyvalent dialysis unit: a review.
    Maggioni S; Hermelin M; Faubel E; Allal A; Kamar N; Rostaing L
    J Ren Care; 2014 Sep; 40(3):164-71. PubMed ID: 24641325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.